Bay City Capital Llc - Dec 3, 2021 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
10%+ Owner
Signature
Bay City Capital LLC, a Delaware limited liability company, By: /s/ Fred Craves, Managing Director
Stock symbol
MDGL
Transactions as of
Dec 3, 2021
Transactions value $
$0
Form type
4
Date filed
12/7/2021, 03:30 PM
Previous filing
Oct 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDGL Common Stock Other $0 -750K -33.19% $0.00 1.51M Dec 3, 2021 See Footnotes F1, F2, F4
transaction MDGL Common Stock Other $0 -49.7K -100% $0.00* 0 Dec 3, 2021 See Footnotes F1, F3, F4
transaction MDGL Common Stock Other $0 -24.2K -95.04% $0.00 1.26K Dec 3, 2021 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Bay City Capital Llc is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.
F2 The securities are held by Fund IV.
F3 The securities were held by Co-Investment IV.
F4 Represents transfers, without the payment of any consideration, to their partners and employees.